Story perspectives

FDA Approves 20 Cancer Drugs Amid Funding Crisis Concerns

10/23/2025

29 7

Summary

Story summary

The U.S. Food and Drug Administration (FDA) approves 20 cancer drugs in 2025, including blood-cancer therapies.
The report warns National Institutes of Health (NIH) budget cuts could trigger a funding crisis.
Non-Hispanic Black individuals face the highest cancer mortality rates.
A national survey shows 83% favor more federal funding for cancer research.
The American Association for Cancer Research (AACR) urges Congress to protect funding for cancer research and prevention programs.

1 of 1

Story summary

The U.S. Food and Drug Administration (FDA) approves 20 cancer drugs in 2025, including blood-cancer therapies.
The report warns National Institutes of Health (NIH) budget cuts could trigger a funding crisis.
Non-Hispanic Black individuals face the highest cancer mortality rates.
A national survey shows 83% favor more federal funding for cancer research.
The American Association for Cancer Research (AACR) urges Congress to protect funding for cancer research and prevention programs.